Anna Jelena Britschgi
Papers
1
Total Citations
32
H-Index
1
About
Anna Jelena Britschgi is a prominent urologic oncologist whose research centers on improving surgical outcomes for prostate cancer, particularly through the refinement of robot-assisted radical prostatectomy techniques. Her major contribution lies in clarifying the prognostic significance of positive surgical margins—a critical factor in predicting cancer recurrence after surgery. In her landmark 2018 study, published in *World Journal of Urology*, Britschgi analyzed a large patient cohort to demonstrate that multifocal positive margins carry a worse prognosis than unifocal ones, providing surgeons with actionable insights for tailoring postoperative surveillance and adjuvant therapy. This work, which has garnered over 30 citations, has influenced clinical guidelines and sparked further investigation into margin assessment. Britschgi’s research bridges the gap between surgical precision and long-term oncologic outcomes, making her a key voice in the era of minimally invasive prostate cancer treatment. Her dedication to evidence-based practice continues to shape how urologists interpret and act on pathological findings, ultimately improving patient care.
Research Focus
Key Achievements
Top Papers
- 1